HUE031329T2 - Humán növekedési hormon stabil folyékony készítménye - Google Patents
Humán növekedési hormon stabil folyékony készítményeInfo
- Publication number
- HUE031329T2 HUE031329T2 HUE06769186A HUE06769186A HUE031329T2 HU E031329 T2 HUE031329 T2 HU E031329T2 HU E06769186 A HUE06769186 A HU E06769186A HU E06769186 A HUE06769186 A HU E06769186A HU E031329 T2 HUE031329 T2 HU E031329T2
- Authority
- HU
- Hungary
- Prior art keywords
- growth hormone
- liquid formulation
- human growth
- stable liquid
- stable
- Prior art date
Links
- 102000002265 Human Growth Hormone Human genes 0.000 title 1
- 108010000521 Human Growth Hormone Proteins 0.000 title 1
- 239000000854 Human Growth Hormone Substances 0.000 title 1
- 239000012669 liquid formulation Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/KR2006/002640 WO2008004717A1 (en) | 2006-07-06 | 2006-07-06 | A stable liquid formulation of human growth hormone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE031329T2 true HUE031329T2 (hu) | 2017-07-28 |
Family
ID=38894670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE06769186A HUE031329T2 (hu) | 2006-07-06 | 2006-07-06 | Humán növekedési hormon stabil folyékony készítménye |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8409586B2 (hu) |
| EP (1) | EP2049148B1 (hu) |
| JP (1) | JP5180202B2 (hu) |
| CN (1) | CN101505789A (hu) |
| BR (1) | BRPI0621841B8 (hu) |
| ES (1) | ES2605022T3 (hu) |
| HK (1) | HK1216992A1 (hu) |
| HU (1) | HUE031329T2 (hu) |
| LT (1) | LT2049148T (hu) |
| PT (1) | PT2049148T (hu) |
| WO (1) | WO2008004717A1 (hu) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011001273A (ja) * | 2009-06-16 | 2011-01-06 | Eci Inc | ｅＭＩＰを有効成分とする水溶性製剤 |
| US20120270782A1 (en) * | 2009-11-17 | 2012-10-25 | Ipsen Pharma S.A.S. | Formulation for hgh and rhigf-1 combination |
| WO2013096835A1 (en) * | 2011-12-23 | 2013-06-27 | Abbvie Inc. | Stable protein formulations |
| EP3068374A1 (en) * | 2013-11-12 | 2016-09-21 | Cadila Healthcare Limited | Formulation for gonadotropins |
| US9908976B2 (en) | 2015-03-18 | 2018-03-06 | Psmg, Llc | Stable polyethylene glycol particle dispersions and methods for forming the stable dispersions |
| CN110151988A (zh) * | 2018-02-11 | 2019-08-23 | 百奥泰生物制药股份有限公司 | 一种靶向治疗TNF-α相关疾病的人抗体制剂 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61296598A (ja) | 1985-06-21 | 1986-12-27 | Mitsubishi Electric Corp | Ｍｏｓダイナミツクｒａｍのダミ−ワ−ド線駆動回路 |
| ES2044941T5 (es) * | 1987-08-21 | 1999-02-16 | Mallinckrodt Group Inc | Estabilizador de hormonas promotoras del crecimiento. |
| US5981485A (en) | 1997-07-14 | 1999-11-09 | Genentech, Inc. | Human growth hormone aqueous formulation |
| MD1699F2 (ro) * | 1992-07-31 | 2001-07-31 | Genentech, Inc. | Compoziţie apoasă a hormonului somatotrop uman şi procedeu de prevenire a denaturării ei |
| ZA965368B (en) * | 1995-07-14 | 1997-01-14 | Novo Nordisk As | A pharmaceutical formulation |
| KR970006498A (ko) | 1995-07-31 | 1997-02-21 | 유충식 | 활성형 인성장호르몬의 정제 방법 |
| AUPN801296A0 (en) * | 1996-02-12 | 1996-03-07 | Csl Limited | Stabilised growth hormone formulation and method of preparation thereof |
| US20020077461A1 (en) * | 1996-04-24 | 2002-06-20 | Soren Bjorn | Pharmaceutical formulation |
| KR100210840B1 (ko) | 1996-12-24 | 1999-07-15 | 구본준 | 기계 화학적 연마 방법 및 그 장치 |
| KR19990001217A (ko) | 1997-06-13 | 1999-01-15 | 윤종용 | 스탠바이 모드에서의 시스템 구동방법 및 장치 |
| JP3723857B2 (ja) | 1998-02-04 | 2005-12-07 | 日本ケミカルリサーチ株式会社 | ヒト成長ホルモン含有水性医薬組成物 |
| KR100316347B1 (ko) | 1998-09-15 | 2002-08-27 | 한미약품(주) | 대장균엔테로톡신ⅱ신호펩티드의변형체와인체성장호르몬의융합단백질을발현하는재조합미생물및그를이용한인체성장호르몬의제조방법 |
| KR100573704B1 (ko) | 1998-12-02 | 2006-07-21 | 동아제약주식회사 | 인성장 호르몬의 안정화된 액상제제_ |
| HUP0203133A3 (en) | 1999-10-04 | 2005-07-28 | Chiron Corp Emeryville | Stabilized liquid polypeptide-containing pharmaceutical compositions |
| KR100499655B1 (ko) | 1999-10-08 | 2005-07-07 | 넥타르 테라퓨틱스 에이엘, 코포레이션 | 헤테로 이작용성 폴리(에틸렌 글리콜) 유도체 및 그의제조 방법 |
| US6719992B2 (en) * | 2000-06-26 | 2004-04-13 | Monsanto Technology Llc | Non-aqueous surfactant-containing formulations for extended release of somatotropin |
| JP2005535652A (ja) * | 2002-07-09 | 2005-11-24 | サンド・アクチエンゲゼルシヤフト | １，２−プロピレングリコールを含有するヒト成長ホルモン（ｈＧＨ）の高濃度液体製剤 |
| WO2004082707A2 (en) * | 2003-03-18 | 2004-09-30 | Ares Trading Sa | Stabilisation of growth hormones in solution |
| KR100537260B1 (ko) | 2003-09-03 | 2005-12-19 | 한미약품 주식회사 | 인간 성장 호르몬의 안정화된 액상 제제용 조성물 |
| EP1667724A2 (en) * | 2003-09-19 | 2006-06-14 | Novo Nordisk A/S | Albumin-binding derivatives of therapeutic peptides |
| EP1663296A4 (en) * | 2003-09-25 | 2009-11-25 | Cangene Corp | LIQUID FORMULATION OF HUMAN GROWTH HORMONE CONTAINING POLYETHYLENE GLYCOL |
| DE10355189B4 (de) * | 2003-11-26 | 2015-04-30 | Johnson & Johnson Medical Gmbh | Verfahren zum Herstellen eines chirurgischen Implantats sowie chirurgisches Implantat |
| CA2551510C (en) * | 2003-12-23 | 2013-07-30 | Pharmacia Corporation | Stable growth hormone liquid formulation |
-
2006
- 2006-07-06 HU HUE06769186A patent/HUE031329T2/hu unknown
- 2006-07-06 JP JP2009517937A patent/JP5180202B2/ja active Active
- 2006-07-06 PT PT67691865T patent/PT2049148T/pt unknown
- 2006-07-06 EP EP06769186.5A patent/EP2049148B1/en active Active
- 2006-07-06 CN CNA2006800556995A patent/CN101505789A/zh active Pending
- 2006-07-06 US US12/307,661 patent/US8409586B2/en active Active
- 2006-07-06 ES ES06769186.5T patent/ES2605022T3/es active Active
- 2006-07-06 LT LTEP06769186.5T patent/LT2049148T/lt unknown
- 2006-07-06 WO PCT/KR2006/002640 patent/WO2008004717A1/en active Application Filing
- 2006-07-06 BR BRPI0621841A patent/BRPI0621841B8/pt active IP Right Grant
-
2016
- 2016-04-29 HK HK16104967.3A patent/HK1216992A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2605022T3 (es) | 2017-03-10 |
| BRPI0621841A2 (pt) | 2011-12-20 |
| EP2049148A4 (en) | 2013-12-11 |
| LT2049148T (lt) | 2016-11-25 |
| EP2049148A1 (en) | 2009-04-22 |
| EP2049148B1 (en) | 2016-09-28 |
| BRPI0621841B1 (pt) | 2020-12-29 |
| JP5180202B2 (ja) | 2013-04-10 |
| PT2049148T (pt) | 2016-12-30 |
| BRPI0621841B8 (pt) | 2021-05-25 |
| WO2008004717A1 (en) | 2008-01-10 |
| WO2008004717A9 (en) | 2013-08-29 |
| HK1216992A1 (zh) | 2016-12-16 |
| US20090298768A1 (en) | 2009-12-03 |
| JP2009542629A (ja) | 2009-12-03 |
| US8409586B2 (en) | 2013-04-02 |
| CN101505789A (zh) | 2009-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1216992A1 (zh) | 穩定的人生長激素液體製劑 | |
| EP2593084A4 (en) | LIQUID FORMULATION FROM HUMAN GROWTH HORMONE CONJUGATES WITH LONG-TERM EFFECT | |
| ZA200904544B (en) | Stable S-(+)-abscisic acid liquid and soluble granule formulations | |
| EP2081502B8 (en) | A medical device for attaching tissue to bone | |
| PL2007356T3 (pl) | Preparaty lipopleksowe przeznaczone do swoistego dostarczania do tkanek naczyniowych śródbłonka | |
| HK1181633A1 (en) | Endoscopic delivery of medical devices | |
| EP1942981A4 (en) | DISTRIBUTION OF MEDIUM TO TISSUE | |
| ZA200900345B (en) | Preparation of pharmaceutical formulations | |
| EP2081607A4 (en) | HYGIENE TOWEL WITH A MICROBIAL SUPPRESSIVE COMPOSITION | |
| PL1570866T3 (pl) | Sposób dostarczania płynnego środka sterylizującego do sterylizatora | |
| HK1200019A1 (en) | Use of a liquid allergy vaccine formulation for oromucosal administration | |
| HK1142536A1 (en) | Gel useful for the delivery of cosmetic active ingredients | |
| ZA200900125B (en) | Liquid formulation of pyrethroids | |
| ZA200704926B (en) | Modified human growth hormone | |
| HK1131546A1 (en) | Subcutaneous implants releasing an active principle over an extended period of time | |
| IL213711A (en) | Nano-phenofibrate preparation | |
| IL195034A0 (en) | Liquid pharmaceutical formulation | |
| EP2073631A4 (en) | AGROCHEMICAL FORMULATIONS OF LIQUID CRYSTALS | |
| HK1215930A1 (zh) | 穩定的人生長激素液體製劑 | |
| HK1144295A1 (en) | Stable liquid formulation | |
| IL199756A0 (en) | Medically active plaster | |
| GB0813004D0 (en) | Stable therapeutic formulation of human growth hormone | |
| GB2451360B (en) | Hormone replacement formulation | |
| EP2005955A4 (en) | UNSATURATED SALT FORMULATION OF AMPELOPSIN AND CORRESPONDING APPLICATION | |
| GB0610207D0 (en) | New forms of active pharmaceutical ingredient |